Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma

Journal: Nature Medicine

Published: 2018-11-19

DOI: 10.1038/s41591-018-0243-z

Affiliations: 12

Authors: 27

Go to article
Institutions FC
Peter MacCallum Cancer Centre (Peter Mac), Australia 0.37
Sir Peter MacCallum Department of Oncology, UniMelb, Australia 0.19
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia 0.09
Department of Medical Biology, UniMelb, Australia 0.09
Victorian Comprehensive Cancer Centre (VCCC), Australia 0.09
Royal Melbourne Hospital (RMH), Australia 0.07
University Medical Center Schleswig-Holstein - Campus Kiel (UKSH Kiel), Germany 0.04
St Vincent's Hospital Melbourne, Australia 0.03
University of Melbourne Centre for Cancer Research (UMCCR), UniMelb, Australia 0.03
St Vincent's Institute of Medical Research (SVI), Australia 0.01